polymyxin B Variable Concentration Multi-Use Injectable Solution
- RxCUI
- 204509
- RxNorm name
- polymyxin B Variable Concentration Multi-Use Injectable Solution
- Display name
- polymyxin B Variable Concentration Multi-Use Injectable Solution
- Full name
- polymyxin B Variable Concentration Multi-Use Injectable Solution
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:22
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Polymyxin B | POLYMYXIN B SULFATE | Xellia Pharmaceuticals USA LLC | b56f18c0-ef5e-4ed9-a5af-f79f3cd189b6 | 2026-06-22 | Boxed warning, Warnings, Adverse reactions | 204509 |
| Polymyxin B | POLYMYXIN B SULFATE | Sagent Pharmaceuticals | 7dc505aa-64b0-4b7f-8ee3-2945bde40a34 | 2025-10-01 | Boxed warning, Warnings, Adverse reactions | 204509 |
| POLYMYXIN B | POLYMYXIN B SULFATE | FOSUN PHARMA USA INC | fd664927-db58-a1af-e053-6294a90a9048 | 2025-05-29 | Boxed warning, Warnings, Adverse reactions | 204509 |
| Polymyxin B | POLYMYXIN B SULFATE | Hikma Pharmaceuticals USA Inc. | d2bf65f6-2763-4859-a665-ad5e6cde71ee | 2025-05-23 | Boxed warning, Warnings, Adverse reactions | 204509 |
| Polymyxin B | POLYMYXIN B | Eugia US LLC | a974c557-e88f-451b-a1bd-d2c656be226e | 2025-05-09 | Boxed warning, Warnings, Adverse reactions | 204509 |
| POLYMYXIN B | POLYMYXIN B SULFATE | Gland Pharma Limited | dc74dee2-1d0b-4fab-a29b-1755fdb5da75 | 2025-05-09 | Boxed warning, Warnings, Adverse reactions | 204509 |
| Polymyxin B | POLYMYXIN B SULFATE | Fresenius Kabi USA, LLC | 72dd6de6-31d6-4a8f-881b-91af91ed9314 | 2022-12-01 | Boxed warning, Warnings, Adverse reactions | 204509 |
| Polymyxin B | POLYMYXIN B SULFATE | Hikma Pharmaceuticals USA Inc. | 18daf0d1-b6f5-46f4-ab2f-01a594f3959c | 2022-04-28 | Boxed warning, Warnings, Adverse reactions | 204509 |
| POLYMYXIN B | POLYMYXIN B SULFATE | Fresenius Kabi USA, LLC | 704a41f5-b109-4c16-8d3e-1495c9917952 | 2021-05-31 | Boxed warning, Warnings, Adverse reactions | 204509 |
| POLYMYXIN B | POLYMYXIN B SULFATE | Fresenius Kabi USA, LLC | fbc12c18-567b-41bc-89d0-efd29616615c | 2021-02-28 | Boxed warning, Warnings, Adverse reactions | 204509 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| d2bf65f6-2763-4859-a665-ad5e6cde71ee | polymyxin B Variable Concentration Multi-Use Injectable Solution [PSN] · polymyxin B 250000 UNT/ML Injectable Solution [SCD] | 2 | 13 | POLYMYXIN B for INJECTION, USP 500,000 Units/vial | 20250523 |
| b56f18c0-ef5e-4ed9-a5af-f79f3cd189b6 | polymyxin B Variable Concentration Multi-Use Injectable Solution [PSN] · polymyxin B 250000 UNT/ML Injectable Solution [SCD] | 2 | 12 | POLYMYXIN B for INJECTION, USP 500,000 Units/vial | 20250423 |
| dc74dee2-1d0b-4fab-a29b-1755fdb5da75 | polymyxin B Variable Concentration Multi-Use Injectable Solution [PSN] · polymyxin B 250000 UNT/ML Injectable Solution [SCD] | 2 | 9 | Polymyxin B for Injection, USP 500,000 Units Rx Only To reduce the development of drug-resistant bacteria and maintain the effectiveness of polymyxin B and other antibacterial drugs, polymyxin B should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 20250509 |
| a974c557-e88f-451b-a1bd-d2c656be226e | polymyxin B Variable Concentration Multi-Use Injectable Solution [PSN] · polymyxin B 250000 UNT/ML Injectable Solution [SCD] | 2 | 7 | 20250509 | |
| fd664927-db58-a1af-e053-6294a90a9048 | polymyxin B Variable Concentration Multi-Use Injectable Solution [PSN] · polymyxin B 250000 UNT/ML Injectable Solution [SCD] | 2 | 4 | Polymyxin B for Injection, USP | 20250529 |
| fbc12c18-567b-41bc-89d0-efd29616615c | polymyxin B Variable Concentration Multi-Use Injectable Solution [PSN] · polymyxin B 250000 UNT/ML Injectable Solution [SCD] | 2 | 4 | 20210228 | |
| 18daf0d1-b6f5-46f4-ab2f-01a594f3959c | polymyxin B Variable Concentration Multi-Use Injectable Solution [PSN] · polymyxin B 250000 UNT/ML Injectable Solution [SCD] | 2 | 3 | Polymyxin B for Injection, USP | 20220428 |
| 132fe072-9c9a-4c56-9004-c27ee6a467ae | polymyxin B Variable Concentration Multi-Use Injectable Solution [PSN] · polymyxin B 250000 UNT/ML Injectable Solution [SCD] | 2 | 3 | Rx ONLY To reduce the development of drug-resistant bacteria and maintain the effectiveness of polymyxin B and other antibacterial drugs, polymyxin B should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 20160216 |
| 72dd6de6-31d6-4a8f-881b-91af91ed9314 | polymyxin B Variable Concentration Multi-Use Injectable Solution [PSN] · polymyxin B 250000 UNT/ML Injectable Solution [SCD] | 2 | 2 | 20221201 | |
| 7dc505aa-64b0-4b7f-8ee3-2945bde40a34 | polymyxin B Variable Concentration Multi-Use Injectable Solution [PSN] · polymyxin B 250000 UNT/ML Injectable Solution [SCD] | 2 | 1 | Polymyxin B for Injection, USP | 20251001 |
| 704a41f5-b109-4c16-8d3e-1495c9917952 | polymyxin B Variable Concentration Multi-Use Injectable Solution [PSN] · polymyxin B 250000 UNT/ML Injectable Solution [SCD] | 2 | 1 | 20210531 |